期刊文献+

强力霉素对溶栓脑缺血大鼠血脑屏障通透性的影响 被引量:2

Influence of doxycycline on the permeability of the brain-blood barrier after urokinase thrombolysis in rats
原文传递
导出
摘要 目的观察强力霉素对脑缺血不同时间尿激酶溶栓大鼠血脑屏障通透性的影响,评价其对溶栓后出血性转化的干预效果。方法采用大鼠自体血栓塞大脑中动脉闭塞(MCAO)模型,分别测定MMP-9表达水平、血脑屏障通透性、脑出血量和出血发生率。结果各时间点尿激酶溶栓治疗使MMP-9表达增加,血脑屏障通透性、脑出血量和出血发生率较对照组增加,且溶栓时间越晚增加越明显;强力霉素联合尿激酶溶栓组与相应时间点尿激酶溶栓组比较MMP-9表达水平和血脑屏障通透性显著降低,而脑出血量和出血发生率均有下降趋势。结论强力霉素联合尿激酶溶栓治疗可降低脑缺血大鼠溶栓后MMP-9高表达,减轻不同时间点尿激酶溶栓后血脑屏障破坏导致的颅内出血性转化。 Objective To study the influnence rier after urokinase thrombolysis therapy at different of doxycycline on the permeability ot the bram-Dlood oartime in rats with thrombusoccluded cerebral ischemia, and to evaluae the effect of doxycyeline on the cerebral hemorrhagic transformation after urokinase thrombolysis therapy. Methods A focal cerebral iscbemia of rats were established by embolizing left middle cerebral artery with autologous blood clots. The expression of MMP-9 was detected with inmmunohistochemical staining, the permeability of the brain-blood barrier was observed with Evan's blue, the rate of cerebral hemorrhage and the cerebral hemorrhage content were quantified with spectrophotometer assay. Results There were increased MMP-9 expression, the permeability of the brain-blood barrier and the cerebral hemorrhage content with urokinose treatment. And there were obviously increased more than 6 hours after ischemic stroke. Doxycycline combined with urokinase thrombolysis therapy decreased MMP-9 expression, the permeability of the brain-blood barrier,the cerebral hemorrhage content and the rate of hemorrhage. Conclusions Doxycycline combined with urokinase attenuates the permeability of the brain blood barrier,and reduces inducing hemorrhagic transformation after urokinase thrombolysis therapy at different time in rats with ischemie stroke model.
出处 《卒中与神经疾病》 2009年第1期30-33,共4页 Stroke and Nervous Diseases
基金 重庆市卫生局资助(04-2-144)
关键词 溶栓 基质金属蛋白酶-9 血脑屏障通透性 强力霉素 Thrombolysis Matrix metalloproteinase-9 Brain-blood barrier Permeability Doxycycline
  • 相关文献

参考文献9

  • 1Tsuji K, Aoki T, Tejima E, et al. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cer ebral ischemia. Stroke,2005,36(9) : 1954-1959.
  • 2张新江,常丽英,张苏明,方思羽.大鼠自体血栓大脑中动脉闭塞模型的改良[J].卒中与神经疾病,2003,10(1):12-15. 被引量:29
  • 3Choudri TF, Hoh BL, Solomon RA, et al. Use of a spectrophoto- metric assay to objectively quantify intracerebral hemorrhage in mice. Stroke, 1997,28 ( 11 ) : 2296-2302.
  • 4Hamacher S, Matern S, Roeh E. Extracellular matrix-from basic research to clinical significance. An overview with special consid eration of matrix metalloproteinases. Dtsch Med Wochens chr, 2004,129: 1976-1980.
  • 5Kelly MA, Shuaib A, Todd KG, et al. Matrix metalloproteinase activation and blood-brain barrier breakdown following throm- bolysis. Exp Neurol, 2006,200 ( 1 ) : 38-49.
  • 6Solomatina MA, Plekhanova OS, Man'shikova MY, et al. Urokinase increases the content and activiy of matrix metalloproteinase-2 and 9 during in vivo constrictive arterial remodeling. Bull Exp Bio Med, 2005,139 (3) : 283-286.
  • 7Pfefferkorn T,Rosenberg GA. Closure of the blood-brain barrier by Metalloproteinase inhibition rtPA-mediated mortality in cere bral ischemia with delayed reperfusion. Stroke, 2003, 34 (8): 2025-2030.
  • 8Montaner J, Molina CA, Monasterio J, et al. Matrix metallopro- teinase9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation, 2003,107 (4) : 598-605.
  • 9Burggraf D, Trinkl A, Dichgans M, et al. Doxycycline inhibits MMPs via modulation of plasminogen activators in focal cerebral ischemia. Neurobiol Dis,2007,25(6) :506-513.

二级参考文献7

  • 1陈俊抛,田时雨.多发性脑梗塞痴呆动物模型的研究[J].中华神经精神科杂志,1994,27(5):311-312. 被引量:121
  • 2[2]Overgaard K, Sereghy J, Boysen G, et al. A rat model of reproducible cerebral infarction using thrombolic clot emboli. J cereb Blood Flow Metab, 1992, 12(3) :484
  • 3[3]Busch E, Kruger K, Hossmann KA. Improved model of thrombolic stroke and r-tPA induced reperfusion in the rat. Brain Res, 1997,778(1):16
  • 4[4]Garcia JH, Wogner S, Liu KF, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stroke, 1995, 26(3):627
  • 5[5]Zhang Z, Chopp M, Zhang RL, et al. Amouse model of embolic focal ischemia. J Cereb Blood Flow Metab, 1997, 17(10): 1081
  • 6[6]Zhang Z, Zhang RL, Jiang Q, et al. A new rat model of thrombolic focal cerebral ischemia. J Cereb Blood Flow Metab, 1997, 17( 1 ):123
  • 7[7]Vanderschuern S, Vlaenderen Ⅳ, Collen D, et al. Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasmanogen activation in a rabbit embolic stroke model. Stroke,1997, 28(7) : 1383

共引文献28

同被引文献43

  • 1Kokoz Y M, Tsyganova V G, Korystova A F, et al. Selective cytostatic and neurotoxic effects of avermectins and activa- tion of the GABAa receptor[J]. Biosci Rep, 1999, 6(19): 535-546.
  • 2De Lange E C M, Marchand S, van den Berg D, et al. In vitro and in vivo investigations on fluoroquinolones: Effects of the P-glycoprotein effiux transporter on brain distribution of sparfloxacin[J]. Eur J Pharm Sci, 2000, 12(2): 85-93.
  • 3Jaehde U, Goto T, de Boer A G, et al. Blood-brain barrier transport rate of quinoline antibacterials evaluated in cere- brovascular endothelial cell cultures[J]. Eur J Pharm Sci,1993, 1(1): 49-55.
  • 4Bilandzic N, Kolanovic B S, Varenina I, et al. Veterinary drug residues determination in raw milk in Croatia[J]. Food Control, 2011, 22(12): 1941-1948.
  • 5Escudero E, Marin P, Chrceles C M, et al. Pharmacokinetic and milk penetration of a difloxacin long-acting poloxamer gel formulation with carboxy-methylcellulose in lactating goats [J]. Vet J, 2011,188(1): 92-95.
  • 6Hoy T, Horsberg T E, Nafstad I. The Disposition of ivermec- tin in Atlantic Salmon (Salmo salar) [J]. Pharmacol Toxicol, 1990(67): 307-312.
  • 7Jen6i6 V, ~eme M, Er~en N K, et al. Abamectin effects on rainbow trout (Oncorhynchus mykiss) [J]. Ecotoxicology, 2006, 3(15): 249-257.
  • 8Roth M, Richards R H, Sommerville C. Current practices in the chemotherapeutic control of sea lice infestations in aq- uaculture-A review[J]. J Fish Dis, 1993(16): 1-26.
  • 9邓艳萍. 氟喹诺酮类药物对小鼠中枢神经毒性及其机制研究. 北京医科大学, 北京. 1999.
  • 10Carbone M, Pennisi M G, Masucci M, et al. Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates[J]. Veterinary Microbiology, 2001, 81(1): 79-84.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部